Back
Acumen Pharmaceuticals, Inc. 10K Form
Sell
50
ABOS
Acumen Pharmaceuticals, Inc.
Last Price:
$1.99
Seasonality Move:
-34.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ABOS News And Ratings
See the #1 stock for the next 7 days that we like better than ABOS
ABOS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-30.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.54 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | -2.20680 |
|---|---|
| Net Income (TTM): | $-133.4M |
| Gross Margin: | $-178K |
| Return on Equity: | -87.18% |
| Return on Assets: | -65.08% |
Acumen Pharmaceuticals, Inc. Earnings Forecast
Key Acumen Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Acumen Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ABOS |
| Website: | acumenpharm.com |
Debt
| Debt-to-Equity Ratio: | 0.33 |
|---|---|
| Current Ratio: | 6.02 |
| Quick Ratio: | 5.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ABOS Technical Analysis vs Fundamental Analysis
Sell
50
Acumen Pharmaceuticals, Inc. (ABOS)
is a Sell
Is Acumen Pharmaceuticals, Inc. a Buy or a Sell?
-
Acumen Pharmaceuticals, Inc. stock is rated a SellThe current Acumen Pharmaceuticals, Inc. [ABOS] share price is $1.93. The Score for ABOS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.